Churg-Strauss syndrome laboratory findings: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 28: Line 28:
'''Biopsy'''
'''Biopsy'''


The gold standard in establishing a diagnosis for Eosinophilic granulomatosis with polyangiitis is a lung biopsy.     
The gold standard in establishing a diagnosis for Eosinophilic granulomatosis with polyangiitis is a lung biopsy.<ref name="pmid7952571">{{cite journal| author=Allen JN, Davis WB| title=Eosinophilic lung diseases. | journal=Am J Respir Crit Care Med | year= 1994 | volume= 150 | issue= 5 Pt 1 | pages= 1423-38 | pmid=7952571 | doi=10.1164/ajrccm.150.5.7952571 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7952571  }} </ref>    





Revision as of 14:43, 18 November 2016

Churg-Strauss syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Churg-Strauss syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Churg-Strauss syndrome laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Churg-Strauss syndrome laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Churg-Strauss syndrome laboratory findings

CDC on Churg-Strauss syndrome laboratory findings

Churg-Strauss syndrome laboratory findings in the news

Blogs on Churg-Strauss syndrome laboratory findings

Directions to Hospitals Treating Churg-Strauss syndrome

Risk calculators and risk factors for Churg-Strauss syndrome laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Ali Poyan Mehr, M.D. [2]Associate Editor(s)-in-Chief: Krzysztof Wierzbicki M.D. [3]

Overview

Laboratory findings consistent with the diagnosis of Eosinophilic granulomatosis with polyangiitis include, antineutrophil cytoplasmic antibodies, hypereosinophilia, and elevated immunoglobulin E titers (IgE).

Laboratory Findings

Laboratory findings consistent with the diagnosis of Eosinophilic granulomatosis with polyangiitis include, antineutrophil cytoplasmic antibodies, hypereosinophilia, and elevated immunoglobulin E titers (IgE). Routine laboratory tests that are used to identify Eosinophilic granulomatosis with polyangiitis are:.[1]

Blood Work-up

  • Complete blood count (CBC)
  • Uremia
  • Serum creatinine
  • Blood urea nitrogen (BUN)
  • Antineutrophil cytoplasmic antibody test
  • Eosinophilia
  • Immunoglobulin
  • Erythrocyte sedimentation rate (ESR)
  • C-reactive protein (CRP)
  • Serum troponin[2]
  • Rheumatoid factor

Urinalysis

  • Proteinuria
  • Microscopic hematuria
  • Albuminuria
  • Red blood cell casts

Biopsy

The gold standard in establishing a diagnosis for Eosinophilic granulomatosis with polyangiitis is a lung biopsy.[3]


References

  1. CHURG J, STRAUSS L (1951). "Allergic granulomatosis, allergic angiitis, and periarteritis nodosa". Am J Pathol. 27 (2): 277–301. PMC 1937314. PMID 14819261.
  2. McAleavey N, Millar A, Pendleton A (2013). "Cardiac involvement as the main presenting feature in eosinophilic granulomatosis with polyangiitis". BMJ Case Rep. 2013 ( ):  . doi:10.1136/bcr-2013-009394. PMC 3736255. PMID 23853013.
  3. Allen JN, Davis WB (1994). "Eosinophilic lung diseases". Am J Respir Crit Care Med. 150 (5 Pt 1): 1423–38. doi:10.1164/ajrccm.150.5.7952571. PMID 7952571.

Template:WH Template:WS